The epidermal growth factor receptor (EGFR) is critical for proliferation and tumorigenesis in ovarian cancer, with it being reported that EGF activates TRPC3/4/5, thus prompting Ca2+ inflow in HEK293 cells (human embryonic kidney 293 cells) [144,145,146,147]. Here, TRPC3 is linked to ovarian carcinoma.